For the study, researchers analyzed data from the Kids’ Inpatient Database. The use of BMP has sparked controversy since its introduction in 2002, with some clinical research suggesting its use in adults is associated with wound dehiscence, spinal stenosis and respiratory stenosis. Orthopedic device giant Medtronic, which manufactures and markets BMP-product InFuse, has funded research that helped bring BMP into the marketplace.
The U.S. Senate Finance Committee is currently investigating financial relationships between Medtronic and physicians who conducted and published positive research results of BMP.
Researchers found that 9.2 percent of pediatric spinal fusion procedures use BMP, which was also shown to add as much as $4,000 to each case.
More Articles on Orthopedic Devices:
Johnson & Johnson Worldwide Medical Device, Diagnostics Sales Reach $7.1B
Brian McCollum to Lead Orthofix Spine Global Business Unit
Lanx Raises $8.7M to Boost Sales of Fusion System, Introduce New Products
